Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cardiva Medical Inc.

www.cardivamedical.com

Latest From Cardiva Medical Inc.

Cardiva Forsees ‘Room To Run’ For Its Unique Vascular Closure Devices

Cardiva Medical is taking advantage of the growing demand for products that safely and quickly close the access sites created for catheter-based electrophysiology procedures and other large-catheter cardiac procedures. The company has a sales staff entirely dedicated to its line of closure devices for multi-site venous closure for 6-12 French inner diameter sheaths, and is investing in clinical trials to show how these devices can improve patients’ recovery time and reduce the risk of complications.

Commercial Clinical Trials

Cardiva's Vascade System Now Approved For Vein Closures After Cardiac Surgery

After receiving US FDA approval to help close arteries following cardiac surgery five years ago, Cardiva Medical says its Vascade system is now also approved to close veins that are typically larger with thinner walls after surgery.

Approvals Clinical Trials

Vascular Closure Market Makes Room For Innovative Solutions

The $1 billion vascular closure market is primed for growth. It comes on the back of intensive R&D that has spawned a range of alternatives to the traditional manual/compression approach, giving SJM and the sector’s other heavyweights cause to look over their shoulders.

Medical Device Surgical Procedures

Device/Diagnostics Quarterly Deal Statistics, Q3 2014

Device financing decreased to $734 million in Q3, less than half the Q2 total, and the $4.9 billion in M&As was a sharp decline versus Q2. Diagnostics fundraising, at $399 million, showed a 31% drop from Q2, and Merck KGAA’s $16.7 billion buy of Sigma-Aldrich made up 96% of the Q3 M&A activity.

Medical Device Deals
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Cardiovascular
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Cardiva Medical Inc.
  • Senior Management
  • John Russell, Pres. & CEO
    Lisa Garrett, CFO
    Zia Yassinzadeh, CTO
    Roger R Owens, Chief Commercial Officer
  • Contact Info
  • Cardiva Medical Inc.
    Phone: (408) 470-7100
    2900 Lakeside Dr., Ste. 160
    Santa Clara, CA 95054
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register